Amneet Sandhu1, Lisa A McCoy2, Smita I Negi2, Irfan Hameed2, Prashant Atri2, Subhi J Al'Aref2, Jeptha Curtis2, Ed McNulty2, H Vernon Anderson2, Adhir Shroff2, Mark Menegus2, Rajesh V Swaminathan2, Hitinder Gurm2, John Messenger2, Tracy Wang2, Steven M Bradley2. 1. From Division of Cardiology, University of Colorado School of Medicine, Aurora (A.S., J.M., S.M.B.); Division of Cardiology, Duke University Medical Center, Durham, NC (L.A.M., T.W.); Division of Cardiology, Medstar Washington Hospital Center/Georgetown University, Washington, DC (S.I.N.); Division of Cardiology, Albert Einstein College of Medicine, Bronx, NY (I.H., M.M.); Division of Cardiology, Northwestern University, Chicago, IL (P.A.); Division of Cardiology, Weill Cornell Medical Center, New York (S.J.A.'A., R.V.S.); Division of Cardiology, Yale/New Haven Medical Center, CT (J.C.); Division of Cardiology, Kaiser Permanente San Francisco Medical Center, CA (E.M.); Division of Cardiology, University of Texas Health Science Center, Houston (H.V.A.); Division of Cardiology, University of Illinois, Chicago (A.S.); Division of Cardiology, University of Michigan, Ann Arbor (H.G.); and Division of Cardiology, VA Eastern Colorado Health Care System, Denver (J.M., S.M.B.). amneet.sandhu@ucdenver.edu. 2. From Division of Cardiology, University of Colorado School of Medicine, Aurora (A.S., J.M., S.M.B.); Division of Cardiology, Duke University Medical Center, Durham, NC (L.A.M., T.W.); Division of Cardiology, Medstar Washington Hospital Center/Georgetown University, Washington, DC (S.I.N.); Division of Cardiology, Albert Einstein College of Medicine, Bronx, NY (I.H., M.M.); Division of Cardiology, Northwestern University, Chicago, IL (P.A.); Division of Cardiology, Weill Cornell Medical Center, New York (S.J.A.'A., R.V.S.); Division of Cardiology, Yale/New Haven Medical Center, CT (J.C.); Division of Cardiology, Kaiser Permanente San Francisco Medical Center, CA (E.M.); Division of Cardiology, University of Texas Health Science Center, Houston (H.V.A.); Division of Cardiology, University of Illinois, Chicago (A.S.); Division of Cardiology, University of Michigan, Ann Arbor (H.G.); and Division of Cardiology, VA Eastern Colorado Health Care System, Denver (J.M., S.M.B.).
Abstract
BACKGROUND: Little is known about the contemporary use of intra-aortic balloon pump (IABP) and other mechanical circulatory support (O-MCS) devices in patients undergoing percutaneous coronary intervention (PCI) in the setting of cardiogenic shock. METHODS AND RESULTS: We identified 76 474 patients who underwent PCI in the setting of cardiogenic shock at one of 1429 National Cardiovascular Data Registry CathPCI participating hospitals from 2009 to 2013. Temporal trends and hospital-level variation in the use of IABP and O-MCS were evaluated. No mechanical circulatory support was used in 41 286 (54%) patients, 29 730 (39%) received IABP only, 2711 (3.5%) received O-MCS only, and 2747 (3.6%) received both IABP and O-MCS. At the start of the study period, 45% of patients undergoing PCI in the setting of cardiogenic shock received an IABP and 6.7% received O-MCS. The proportion of patients receiving IABP declined at an average rate of 0.3% per quarter, whereas the rate of O-MCS use was unchanged over the study period. The predicted probability of IABP use varied significantly by site (hospital median 42%, interquartile range 33% to 51%, range 8% to 85%). The probability of O-MCS use was <5% for half of hospitals and >20% in less than one-tenth of hospitals. CONCLUSIONS: In this large national registry, the use of IABP in the setting of PCI for cardiogenic shock decreased over time without a concurrent increase in O-MCS use. The probability of IABP and O-MCS use varied across hospitals, and the use of O-MCS was clustered at a small number of hospitals.
BACKGROUND: Little is known about the contemporary use of intra-aortic balloon pump (IABP) and other mechanical circulatory support (O-MCS) devices in patients undergoing percutaneous coronary intervention (PCI) in the setting of cardiogenic shock. METHODS AND RESULTS: We identified 76 474 patients who underwent PCI in the setting of cardiogenic shock at one of 1429 National Cardiovascular Data Registry CathPCI participating hospitals from 2009 to 2013. Temporal trends and hospital-level variation in the use of IABP and O-MCS were evaluated. No mechanical circulatory support was used in 41 286 (54%) patients, 29 730 (39%) received IABP only, 2711 (3.5%) received O-MCS only, and 2747 (3.6%) received both IABP and O-MCS. At the start of the study period, 45% of patients undergoing PCI in the setting of cardiogenic shock received an IABP and 6.7% received O-MCS. The proportion of patients receiving IABP declined at an average rate of 0.3% per quarter, whereas the rate of O-MCS use was unchanged over the study period. The predicted probability of IABP use varied significantly by site (hospital median 42%, interquartile range 33% to 51%, range 8% to 85%). The probability of O-MCS use was <5% for half of hospitals and >20% in less than one-tenth of hospitals. CONCLUSIONS: In this large national registry, the use of IABP in the setting of PCI for cardiogenic shock decreased over time without a concurrent increase in O-MCS use. The probability of IABP and O-MCS use varied across hospitals, and the use of O-MCS was clustered at a small number of hospitals.
Authors: David D Berg; Christopher F Barnett; Benjamin B Kenigsberg; Alexander Papolos; Carlos L Alviar; Vivian M Baird-Zars; Gregory W Barsness; Erin A Bohula; Joseph Brennan; James A Burke; Anthony P Carnicelli; Sunit-Preet Chaudhry; Paul C Cremer; Lori B Daniels; Andrew P DeFilippis; Daniel A Gerber; Christopher B Granger; Steven Hollenberg; James M Horowitz; James D Gladden; Jason N Katz; Ellen C Keeley; Norma Keller; Michael C Kontos; Patrick R Lawler; Venu Menon; Thomas S Metkus; P Elliott Miller; Jose Nativi-Nicolau; L Kristin Newby; Jeong-Gun Park; Nicholas Phreaner; Robert O Roswell; Steven P Schulman; Shashank S Sinha; R Jeffrey Snell; Michael A Solomon; Jeffrey J Teuteberg; Wayne Tymchak; Sean van Diepen; David A Morrow Journal: Circ Heart Fail Date: 2019-11-11 Impact factor: 8.790